Oramed Pharmaceuticals Inc. - (ORMP) share price
Oramed Pharmaceuticals Inc. - (NASDAQ:ORMP) last traded at $3.86, down 0.77% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.16B and a 52-week range of $2.19 to $5.47.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $3.86 |
| 1-day move | -0.77% |
| 52-week range | $2.19 - $5.47 |
| Market cap | $0.16B |
| From 52-week high | -29.40% |
| Volume vs average | 0.6x |
| Falling Shares risk score | 10/100 (LOW) |
| Country | United States |
Frequently asked questions
Why is Oramed Pharmaceuticals Inc. - falling today?
Oramed Pharmaceuticals Inc. - (NASDAQ:ORMP) is down 0.77% at its latest quote and trades 29.4% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Oramed Pharmaceuticals Inc. - share price today?
Oramed Pharmaceuticals Inc. - (NASDAQ:ORMP) last traded at $3.86, a -0.77% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Oramed Pharmaceuticals Inc. -?
Oramed Pharmaceuticals Inc. -'s 52-week low is $2.19 and its 52-week high is $5.47; the shares trade 29.4% below the high.
What is the market cap of Oramed Pharmaceuticals Inc. -?
Oramed Pharmaceuticals Inc. - has a market capitalisation of about $0.16B at the latest price.
What are the risks of investing in Oramed Pharmaceuticals Inc. -?
Falling Shares Intelligence rates Oramed Pharmaceuticals Inc. - 10/100 (LOW) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com